Akonni Biosystems
Private Company
Total funding raised: $14.8M
Overview
Akonni Biosystems is a privately held, commercial-stage molecular diagnostics company founded in 2003. It has established itself with a proprietary sample preparation technology, the TruTip system, which provides an alternative to traditional spin columns and magnetic beads for nucleic acid purification. The company operates from a state-of-the-art 20,000 sq. ft. manufacturing facility and serves research and diagnostic markets. Its business model is centered on selling consumable kits and integrated systems, positioning it in the growing sample prep and infectious disease diagnostics sectors.
Technology Platform
Patented TruTip pipette-tip technology for solid-phase nucleic acid extraction and purification, designed for high yield and purity, and compatibility with automation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Akonni competes in the nucleic acid extraction market against giants like Qiagen (spin columns), Thermo Fisher Scientific (magnetic beads), and Roche, as well as numerous smaller firms. Its differentiation is based on claimed superior purity and cost-effectiveness versus columns and beads. In diagnostics, it would face competition from fully integrated MDx systems from companies like Cepheid, BioFire, and Abbott.